Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia

Neuroscience Letters

Volumn 238, Issue 1-2, 1997, Pages 53-56

  Clark, Arthur W ^a   Krekoski, Craig A ^a   Bou, Shao Sun ^a   Chapman, Kevin R ^a   Edwards, Dylan R ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cerebral ischemia; Gelatinase B; Matrix metalloproteinase Gelatinase A; MMP 2; MMP 9; Stroke

Indexed keywords

GELATINASE A; GELATINASE B;

ARTICLE; BRAIN ISCHEMIA; BRAIN TISSUE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROVASCULATURE; PRIORITY JOURNAL; TISSUE SPECIFICITY;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; COLLAGENASES; FEMALE; GELATINASES; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MIDDLE AGED; TIME FACTORS;

EID: 0031459856     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00859-8     Document Type: Article

References (24)

1. Akopov S.E., Simonian N.A., Grigorian G.S. Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke. 27:1996;1739-1743.
2. Colton C.A., Keri J.E., Chen W.T., Monsky W.L. Protease production by cultured microglia: substrate gel analysis and immobilized matrix degradation. J. Neurosci. Res. 35:1993;297-304.
3. Fisher T.C., Meiselmann H.J. Polymorphonuclear leukocytes in ischemic vascular disease. Thromb. Res. 74(Suppl. 1):1994;S21-S34.
4. Hamann G.F., Okada Y., Fitridge R., del Zoppo G.J. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke. 26:1995;2120-2126.
5. Hamann G.F., Okada Y., del Zoppo G.J. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J. Cerebral Blood Flow Metab. 16:1996;1373-1378.
6. Herron G.S., Werb Z., Dwyer K., Banda M.J. Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J. Biol. Chem. 261:1986;2810-2813.
7. Khan K.M.F., Falcone D.J. Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression. J. Biol. Chem. 272:1997;8270-8275.
8. Kleiner D.E., Stetler-Stevenson W.G. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218:1994;325-329.
9. Murphy G., Knauper V. Relating matrix metalloproteinase structure to function: why the 'hemopexin' domain? Matrix Biol. 15:1997;511-518.
10. O'Brien M.D. Ischemic cerebral edema. A review. Stroke. 10:1979;623-628.
11. Romanic A.M., Madri J.A. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol. 4:1994;145-156.
12. Rosenberg G.A. Matrix metalloproteinases in brain injury. J. Neurotrauma. 12:1995;833-842.
13. Rosenberg G.A., Dencoff J.E., Correa N., Reiners M., Ford C.C. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology. 46:1996;1626-1632.
14. Rosenberg G.A., Estrada E.Y., Dencoff J.E., Stetler-Stevenson W.G. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: An expanded therapeutic window. Brain Res. 703:1995;151-155.
15. Rosenberg G.A., Kornfeld M., Estrada E., Kelley R.O., Liotta L.A., Stetler-Stevenson W.G. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res. 576:1992;203-207.
16. Rosenberg G.A., Navratil M. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology. 48:1997;921-926.
17. Rosenberg G.A., Navratil M., Barone F., Feuerstein G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J. Cerebral Blood Flow Metab. 16:1996;360-366.
18. Shaw C.M., Alvord E.C., Berry R.G. Swelling of the brain following ischemic infarction with arterial occlusion. Arch. Neurol. 1:1959;161-177.
19. Tschesche H., Knauper V., Kramer S., Michaelis J., Oberhoff R., Reinke H. Latent collagenase and gelatinase from human neutrophils and their activation. Matrix Suppl. 1:1992;245-255.
20. Tyagi S.C., Kumar S., Cassatt S., Parker J.L. Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in the canine model of coronary artery occlusion. Can. J. Physiol. Pharmacol. 74:1996;983-995.
21. Vartio T., Baumann M. Human gelatinase/type IV procollagenase is a regular plasma component. FEBS Lett. 255:1989;285-289.
22. White O.B., Norris J.W., Hachinski V.C., Lewis A. Death in early stroke, causes and mechanisms (letter). Stroke. 10:1979;743.
23. Woessner J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:1991;2145-2154.
24. Yurchenco P.D., Schittny J.C. Molecular architecture of basement membranes. FASEB J. 4:1990;1577-1590.